Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R. Zasadny

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
FDG metabolism and uptake versus blood flow in women with untreated primary breast cancersKenneth R Zasadny, Mitsuaki Tatsumi, Richard L Wahl
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Diabetes Decreases FDG Accumulation in Primary Lung CancerTatsuo Torizuka, Kenneth R. Zasadny, Richard L. Wahl
Molecular Imaging and Biology|October 11, 2003
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucoseYuji Nakamoto, Kenneth R Zasadny, Heikki Minn, et al.
Molecular Imaging and Biology|October 11, 2003
Comparison of attenuation-corrected and non-corrected FDG-PET images for axillary nodal staging in newly diagnosed breast cancerYuji Nakamoto, Alfred E Chang, Kenneth R Zasadny, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CTKenneth R. Zasadny, Paul V. Kison, Isaac R. Francis, et al.
Nuclear Medicine and Biology|May 29, 2002
Expression of hexokinase II and Glut-1 in untreated human breast cancerRaya S Brown, Tonya M Goodman, Kenneth R Zasadny, et al.
Cancer|March 6, 2002
Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid methodKenneth F Koral, Isaac R Francis, Stewart Kroll, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 20, 2007
Harderian gland adenectomy: a method to eliminate confounding radio-opacity in the assessment of rat brain metabolism by 18F-fluoro-2-deoxy-D-glucose positron emission tomographyDavid W Brammer, Janet M Riley, Steven C Kreuser, et al.
Molecular Imaging and Biology|September 23, 2003
A positron-emitting internal marker for identification of normal tissue by positron emission tomography: phantom studies and validation in patientsCherry T Thomas, Charles R Meyer, Robert A Koeppe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patientsKenneth F Koral, Yuni Dewaraja, Jia Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
FDG metabolism and uptake versus blood flow in women with untreated primary breast cancersKenneth R Zasadny, Mitsuaki Tatsumi, Richard L Wahl
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Diabetes Decreases FDG Accumulation in Primary Lung CancerTatsuo Torizuka, Kenneth R. Zasadny, Richard L. Wahl
Molecular Imaging and Biology|October 11, 2003
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucoseYuji Nakamoto, Kenneth R Zasadny, Heikki Minn, et al.
Molecular Imaging and Biology|October 11, 2003
Comparison of attenuation-corrected and non-corrected FDG-PET images for axillary nodal staging in newly diagnosed breast cancerYuji Nakamoto, Alfred E Chang, Kenneth R Zasadny, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CTKenneth R. Zasadny, Paul V. Kison, Isaac R. Francis, et al.
Nuclear Medicine and Biology|May 29, 2002
Expression of hexokinase II and Glut-1 in untreated human breast cancerRaya S Brown, Tonya M Goodman, Kenneth R Zasadny, et al.
Cancer|March 6, 2002
Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid methodKenneth F Koral, Isaac R Francis, Stewart Kroll, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 20, 2007
Harderian gland adenectomy: a method to eliminate confounding radio-opacity in the assessment of rat brain metabolism by 18F-fluoro-2-deoxy-D-glucose positron emission tomographyDavid W Brammer, Janet M Riley, Steven C Kreuser, et al.
Molecular Imaging and Biology|September 23, 2003
A positron-emitting internal marker for identification of normal tissue by positron emission tomography: phantom studies and validation in patientsCherry T Thomas, Charles R Meyer, Robert A Koeppe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patientsKenneth F Koral, Yuni Dewaraja, Jia Li, et al.
Pageof 2